Avid Organics launches AviGa™ Bio HP70, the first commercial-scale bio-based glycolic acid, offering a sustainable, plant-derived alternative for personal care and pharmaceutical applications.
This launch introduces a significant sustainable alternative in the personal care and pharmaceutical industries, addressing the long-standing reliance on fossil fuels for glycolic acid production. It offers formulators a commercially viable, bio-based option that meets high purity standards, potentially driving broader adoption of sustainable ingredients and reducing the environmental footprint of numerous consumer products.
Avid Organics is launching AviGa™ Bio HP70, the first commercial-scale bio-based glycolic acid.
The product will be available globally from April 14, 2026, with REACH registration for European supply.
AviGa™ Bio HP70 offers a sustainable, plant-derived alternative to petroleum-based glycolic acid for personal care, cosmetics, and pharmaceuticals.
The launch at IN-COSMETICS® Global in Paris highlights the European market's focus on sustainable ingredients. REACH registration is crucial for market access in Europe, indicating a strategic move to cater to this demand.
The product will be available globally from April 14, 2026, with REACH registration for European supply.
AviGa™ Bio HP70 offers a sustainable, plant-derived alternative to petroleum-based glycolic acid for personal care, cosmetics, and pharmaceuticals.
Sign in to save notes on signals.
Sign In